Genetic testing reveals new drug targets in oesophageal cancer
2 September 2015 | By Victoria White
Nearly all advanced oesophageal cancers harbour genetic mutations that can be targeted with emerging drug therapies, according to a new study...
List view / Grid view
News
ESCMID publishes guidelines aimed at preventing build-up of biofilms
2 September 2015 | By Victoria White
ESCMID advocates the need for greater education, guidance and research on the build-up, treatment and prevention of biofilms...
Novogen announces outcome of science review
2 September 2015 | By Victoria White
Novogen has confirmed its scientific review has identified high value opportunities for its technology platforms in areas of unmet patient need...
Positive initial clinical data from Phase 1 trial with ALN-PCSsc
2 September 2015 | By Victoria White
In the Phase 1 study, subcutaneous administration of ALN-PCSsc resulted in an up to 83% lowering of LDL-C, with an up to 64 ± 5% mean maximum reduction, comparable to published results for anti-PCSK9 MAbs...
Bristol-Myers Squibb and QIMR Berghofer Medical Research Institute announce worldwide collaboration to discover novel Immuno-Oncology Antibodies
1 September 2015 | By Charlotte Batchelor
Bristol-Myers Squibb Company and QIMR Berghofer Medical Research Institute have signed a research collaboration and license agreement to discover novel therapeutic antibodies against an undisclosed immuno-oncology...
MISSION Therapeutics appoints Dr Michael Koslowski as Chief Medical Officer
1 September 2015 | By Nick Jackson
Dr Koslowski brings over 15 years’ experience across biopharmaceutical research and development, specialising in drug target discovery and clinical validation...
Scientists identify potential drug therapy for tinnitus
28 August 2015 | By Victoria White
Researchers from University of Pittsburg have discovered the molecular mechanisms behind resilience to noise-induced tinnitus...
Nerve growth factor triggers functional cell growth in Alzheimer’s disease
28 August 2015 | By Victoria White
Degenerating neurons in patients with Alzheimer's disease measurably responded to a gene therapy in which nerve growth factor was injected into their brains...
Flu remedies help combat E. coli
26 August 2015 | By Victoria White
Physiologists from the University of Zurich have now discovered why the intestinal bacterium E. coli multiplies heavily and has an inflammatory effect...
Human RSV study launched to aid vaccine development
26 August 2015 | By Victoria White
A new study will expose healthy adult volunteers to respiratory syncytial virus (RSV), a virus that causes cold-like symptoms in adults...
Immatics US launched to develop adoptive cellular therapies
26 August 2015 | By Victoria White
Immatics US is a new company aimed at becoming a global leader in adoptive cellular therapies (ACT) for the treatment of a range of tumour types...
Oncodrone to progress prostate cancer drug with €2.5m grant
25 August 2015 | By Victoria White
Oncodrone, the anti-cancer company based in Nijmegen, has been granted a € 2,5 million Eurostars grant for the development of its lead drug OCD155...
Major advance towards long-lasting universal influenza vaccine
25 August 2015 | By Victoria White
Scientists from The Scripps Research Institute (TSRI) and Janssen have found a way to induce antibodies to fight a wide range of influenza subtypes...
MorphoSys and Immatics enter immuno-oncology alliance
25 August 2015 | By Victoria White
MorphoSys and Immatics have formed an alliance to generate antibody-based therapeutics against multiple proprietary cancer antigens recognised by T cells...
Ocata receives SBIR grant to develop HMC therapy for lupus nephritis
24 August 2015 | By Victoria White
Ocata has been awarded a SBIR Phase 1 grant to fund further preclinical development of Ocata’s proprietary Hemangio-derived Mesenchymal Cell (HMC) product...
